TB in children

Elizabeth Whittaker, Christine Jones, Beate Kampmann

Source: Eur Respir Monogr 2012; 58: 206-218
Journal Issue: Tuberculosis
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elizabeth Whittaker, Christine Jones, Beate Kampmann. TB in children. Eur Respir Monogr 2012; 58: 206-218

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012


Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004



The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Prevention of TB in areas of low incidence
Source: Eur Respir Mon 2012; 58: 72-83
Year: 2012


Tuberculosis therapy: past, present and future
Source: Eur Respir J 2002; 20: 87S-94S
Year: 2002



HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

TB drug resistance in high-incidence countries
Source: Eur Respir Mon 2012; 58: 95-110
Year: 2012


The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012



Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?
Source: Eur Respir J 2005; 25: 751-757
Year: 2005



The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results
Source: Eur Respir J 2011; 38: 1374-1381
Year: 2011



Childhood tuberculosis in Israel: epidemiological trends and treatment outcomes, 1999–2010
Source: Eur Respir J 2013; 41: 1157-1162
Year: 2013



Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


The role of virus infections in asthma: immune responses and future possibilities
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



Recurrence of tuberculosis in a low-incidence setting
Source: Eur Respir J 2009; 33: 160-167
Year: 2009



M. tuberculosis: immunology and vaccination
Source: Eur Respir J 2001; 17: 537-557
Year: 2001



Unmasking tuberculosis in the era of antiretroviral treatment
Source: Eur Respir J 2012; 39: 1064-1075
Year: 2012



Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007



Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel
Source: Eur Respir J 2008; 32: 413-418
Year: 2008